Graves’ Disease treatment with radioiodine (131I) 10 mCi: clinical experience of a central hospital

IF 0.2 Q4 ENDOCRINOLOGY & METABOLISM

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo Pub Date : 2019-01-01 DOI:10.26497/ao180065

A. Martins, A. S. Osório, V. Gomes, R. Vaz, G. Cantinho, Maria João M Bugalho

{"title":"Graves’ Disease treatment with radioiodine (131I) 10 mCi: clinical experience of a central hospital","authors":"A. Martins, A. S. Osório, V. Gomes, R. Vaz, G. Cantinho, Maria João M Bugalho","doi":"10.26497/ao180065","DOIUrl":null,"url":null,"abstract":"https://doi.org/10.26497/ao180065 1646-3439/© 2019 Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Publicado por Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Este é um artigo Open Access sob uma licença CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). * Autor Correspondente / Corresponding Author. E-Mail: anafgmartins@gmail.com (Ana Martins) Av. Prof. Egas Moniz, 1649-035 Lisboa Introduction: The aim of our study was to determine the effi cacy of 10 mCi fi xed-dose regimen of radioiodine (131I) in the treatment of Graves’ hyperthyroidism and to identify potential cure predictors. Material and Methods: We audited the outcome of Graves’ disease adult patients followed at the outpatient endocrine department who performed a fi rst 10 mCi fi xed-dose regimen between 2008 and 2015. T student and Mann-Whitney tests were used to compare continuous variables normally and non-normally distributed, respectively. Logistic regression was used to determine which factors","PeriodicalId":41840,"journal":{"name":"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26497/ao180065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

https://doi.org/10.26497/ao180065 1646-3439/© 2019 Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Publicado por Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Este é um artigo Open Access sob uma licença CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). * Autor Correspondente / Corresponding Author. E-Mail: anafgmartins@gmail.com (Ana Martins) Av. Prof. Egas Moniz, 1649-035 Lisboa Introduction: The aim of our study was to determine the effi cacy of 10 mCi fi xed-dose regimen of radioiodine (131I) in the treatment of Graves’ hyperthyroidism and to identify potential cure predictors. Material and Methods: We audited the outcome of Graves’ disease adult patients followed at the outpatient endocrine department who performed a fi rst 10 mCi fi xed-dose regimen between 2008 and 2015. T student and Mann-Whitney tests were used to compare continuous variables normally and non-normally distributed, respectively. Logistic regression was used to determine which factors

查看原文本刊更多论文

放射性碘(131I) 10mci治疗Graves病:某中心医院临床体会

https://doi.org/10.26497/ao180065 1646-3439/©2019葡萄牙内分泌学会，糖尿病和代谢学。葡萄牙内分泌学会，糖尿病代谢学。Este artigo开放存取许可协议 CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/)。*作者/通讯作者。E-Mail: anafgmartins@gmail.com (Ana Martins) Av. Egas Moniz教授，1649-035 Lisboa简介:我们研究的目的是确定10 mCi固定剂量放射性碘(131I)治疗Graves甲亢的疗效，并确定潜在的治愈预测因子。材料和方法:我们对2008年至2015年间在门诊内分泌科接受第一个10 mCi固定剂量方案随访的Graves病成年患者的结果进行了审计。分别采用T - student检验和Mann-Whitney检验比较正态分布和非正态分布的连续变量。使用逻辑回归来确定哪些因素

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo ENDOCRINOLOGY & METABOLISM-

自引率

0.00%

发文量